Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Moise, P. A.
400  Ergebnisse:
Personensuche X
?
1

Overview and Comparison of Frameworks for the Valuation of ..:

Maervoet, J ; Moise, P ; Naidoo, S
Value in Health.  19 (2016)  3 - p. A168 , 2016
Link: https://doi.org/10.1016/..
 
?
2

Do Patient Reported Outcomes (Pro) In Oncology Matter In He..:

Casamayor, M ; Palazzolo, D ; Gubbels, L...
Value in Health.  18 (2015)  7 - p. A471 , 2015
Link: https://doi.org/10.1016/..
 
?
3

Manufacturers' Reactions in Response to the New Requirement..:

Moïse, P ; Yocolly, A
Value in Health.  18 (2015)  7 - p. A560 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Identifying Symptoms and Impacts Experienced by Men with No..:

Moïse, P. ; Tomaszewski, E.L. ; Krupnick, R....
Value in Health.  17 (2014)  3 - p. A94 , 2014
Link: https://doi.org/10.1016/..
 
?
5

Recruiting and Interviewing Non-Metastatic Castration-Resis..:

Tomaszewski, E.L. ; Krupnick, R. ; Moïse, P...
Value in Health.  17 (2014)  3 - p. A93-A94 , 2014
Link: https://doi.org/10.1016/..
 
?
6

Are ICER Threshold Values Malleable? The Case of Life-Exten..:

Moïse, P. ; Sweeney, N. ; Lie, X.
Value in Health.  16 (2013)  7 - p. A424-A425 , 2013
Link: https://doi.org/10.1016/..
 
?
7

Scoring Innovation And Clinical Benefit For The Allocation ..:

Purchase, J.L. ; Moïse, P.
Value in Health.  16 (2013)  3 - p. A264 , 2013
Link: https://doi.org/10.1016/..
 
?
8

PCN112 Lessons Learned From HTA Cost Effectiveness Evaluati..:

Moïse, P. ; Fassler, P. ; Holmstrom, S.
Value in Health.  15 (2012)  4 - p. A228 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Reduced Susceptibility to Host-Defense Cationic Peptides an..:

Mishra, N. N. ; Bayer, A. S. ; Moise, P. A...
Journal of Infectious Diseases.  206 (2012)  8 - p. 1160-1167 , 2012
Link: https://doi.org/10.1093/..
 
?
10

PCN149 Uncertainty Regarding NICE's End-of-Life Small Patie..:

Moïse, P. ; Sweeney, N. ; Holmstrom, S.
Value in Health.  15 (2012)  7 - p. A436-A437 , 2012
Link: https://doi.org/10.1016/..
 
?
11

PRM27 Evaluating European Data Sources for Assessing Real-W..:

Moïse, P. ; Andreykiv, M. ; van Engen, A....
Value in Health.  15 (2012)  7 - p. A464-A465 , 2012
Link: https://doi.org/10.1016/..
 
?
12

PCN90 PRO INSTRUMENTS USED TO MEASURE SYMPTOM IMPACTS OF FA..:

Peeters, P. ; Casamayor, M. ; Moïse, P..
Value in Health.  14 (2011)  3 - p. A171 , 2011
Link: https://doi.org/10.1016/..
 
?
13

PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE M..:

Peeters, P. ; Casamayor, M. ; Moïse, P..
Value in Health.  14 (2011)  3 - p. A170-A171 , 2011
Link: https://doi.org/10.1016/..
 
?
14

PCN105 ESTIMATING NICE'S COST EFFECTIVE THRESHOLD FOR END-O..:

Moïse, P. ; Fassler, P.
Value in Health.  14 (2011)  3 - p. A173 , 2011
Link: https://doi.org/10.1016/..
 
?
15

Genotypic and phenotypic relationships among methicillin-re..:

Moise, P. A. ; Smyth, D. S. ; Robinson, D. A....
Journal of Antimicrobial Chemotherapy.  63 (2009)  5 - p. 873-876 , 2009
Link: https://doi.org/10.1093/..
 
1-15